Amgen to buy Horizon for $28B in the year’s biggest pharma takeover

Amgen plans to buy Horizon Therapeutics for about $28 billion in cash, bringing on board two blockbuster drugs to ease the hit the biotech giant faces from biosimilar competition. The companies announced the deal in a press release Monday morning, about two weeks after it was disclosed that Amgen, Sanofi…

...

Click to view original post